{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:06:21Z","timestamp":1787069181928,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02750-x","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T09:07:43Z","timestamp":1766999263000},"page":"493-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Rare forms of congenital adrenal hyperplasia: pathogenesis, clinical, treatment and management"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2386-7307","authenticated-orcid":false,"given":"Paolo","family":"Cavarzere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lupieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Battiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Mancioppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Maffeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"2750_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cen.14109","volume":"92","author":"F Buonocore","year":"2020","unstructured":"Buonocore F, Achermann JC (2020) Primary adrenal insufficiency: new genetic causes and their long-term consequences. Clin Endocrinol (Oxf) 92:11\u201320. https:\/\/doi.org\/10.1111\/cen.14109","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2750_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.20945\/2359-3997000000438","volume":"66","author":"CE Kater","year":"2022","unstructured":"Kater CE, Giorgi RB, Costa-Barbosa FA (2022) Classic and current concepts in adrenal steroidogenesis: a reappraisal. Arch Endocrinol Metab 66:77\u201387. https:\/\/doi.org\/10.20945\/2359-3997000000438","journal-title":"Arch Endocrinol Metab"},{"key":"2750_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbadis.2011.02.003","volume":"1812","author":"S Chung","year":"2011","unstructured":"Chung S, Son GH, Kim K (2011) Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochim Biophys Acta 1812:581\u201391. https:\/\/doi.org\/10.1016\/j.bbadis.2011.02.003","journal-title":"Biochim Biophys Acta"},{"key":"2750_CR4","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, Meyer-Bahlburg HFL, Miller WL, Murad MH, Oberfield SE, White PC (2018) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103:4043\u20134088. https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"HL Claahsen-van der Grinten","year":"2022","unstructured":"Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, Fl\u00fcck CE, Guasti L, Huebner A, Kortmann BBM, Krone N, Merke DP, Miller WL, Nordenstr\u00f6m A, Reisch N, Sandberg DE, Stikkelbroeck NMML, Touraine P, Utari A, Wudy SA, White PC (2022) Congenital adrenal Hyperplasia-Current insights in Pathophysiology, Diagnostics, and management. Endocr Reviews 43:91\u2013159. https:\/\/doi.org\/10.1210\/endrev\/bnab016","journal-title":"Endocr Reviews"},{"key":"2750_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7010011","volume":"7","author":"NL Heather","year":"2021","unstructured":"Heather NL, Nordenstrom A (2021) Newborn screening for CAH-challenges and opportunities. Int J Neonatal Screen 7:11. https:\/\/doi.org\/10.3390\/ijns7010011","journal-title":"Int J Neonatal Screen"},{"key":"2750_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, Reisch N (2023) Congenital adrenal hyperplasia. Lancet 401:227\u2013244. https:\/\/doi.org\/10.1016\/S0140-6736(22)01330-7","journal-title":"Lancet"},{"key":"2750_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ecl.2020.10.008","volume":"50","author":"S Jha","year":"2021","unstructured":"Jha S, Turcu AF (2021) Non-classic congenital adrenal hyperplasia: what do endocrinologists need to know? Endocrinol Metab Clin North Am 50:151\u2013165. https:\/\/doi.org\/10.1016\/j.ecl.2020.10.008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2750_CR9","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-18-0279","volume":"179","author":"WL Miller","year":"2018","unstructured":"Miller WL (2018) Mechanisms in endocrinology: rare defects in adrenal steroidogenesis. Eur J Endocrinol 179:R125\u2013R141. https:\/\/doi.org\/10.1530\/EJE-18-0279","journal-title":"Eur J Endocrinol"},{"key":"2750_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/BF03345731","volume":"32","author":"M Wasniewska","year":"2009","unstructured":"Wasniewska M, Arrigo T, Lombardo F, Crisafulli G, Salzano G, De Luca F (2009) 11-Hydroxylase deficiency as a cause of pre-pubertal gynecomastia. J Endocrinol Invest 32:387\u2013388. https:\/\/doi.org\/10.1007\/BF03345731","journal-title":"J Endocrinol Invest"},{"key":"2750_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s13312-015-0758-z","volume":"52","author":"MC Konar","year":"2015","unstructured":"Konar MC, Goswami S, Babu BG, Mallick AK (2015) Hypoglycemia due to 3\u03b2-hydroxysteroid dehydrogenase type II deficiency in a newborn. Indian Pediatr 52:981\u2013983. https:\/\/doi.org\/10.1007\/s13312-015-0758-z","journal-title":"Indian Pediatr"},{"key":"2750_CR12","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJM199612193352503","volume":"335","author":"HS Bose","year":"1996","unstructured":"Bose HS, Sugawara T, Strauss JF 3rd, Miller WL (1996) The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 335:1870\u20131878. https:\/\/doi.org\/10.1056\/NEJM199612193352503","journal-title":"N Engl J Med"},{"key":"2750_CR13","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1126\/science.7892608","volume":"267","author":"D Lin","year":"1995","unstructured":"Lin D, Sugawara T, Strauss JF 3rd, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828\u20131831. https:\/\/doi.org\/10.1126\/science.7892608","journal-title":"Science"},{"key":"2750_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ejhg.2013.197","volume":"22","author":"S Menab\u00f2","year":"2014","unstructured":"Menab\u00f2 S, Polat S, Baldazzi L, Kulle AE, Holterhus PM, Gr\u00f6tzinger J, Fanelli F, Balsamo A, Riepe FG (2014) Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations. Eur J Hum Genet 22:610\u2013616. https:\/\/doi.org\/10.1038\/ejhg.2013.197","journal-title":"Eur J Hum Genet"},{"key":"2750_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsbmb.2016.03.006","volume":"165","author":"N Kandemir","year":"2017","unstructured":"Kandemir N, Yilmaz DY, Gonc EN, Ozon A, Alikasifoglu A, Dursun A, Ozgul RK (2017) Novel and prevalent CYP11B1 gene mutations in Turkish patients with 11-\u03b2 hydroxylase deficiency. J Steroid Biochem Mol Biol 165:57\u201363. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.03.006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR16","doi-asserted-by":"publisher","first-page":"e3714","DOI":"10.1210\/clinem\/dgab225","volume":"106","author":"M Yildiz","year":"2021","unstructured":"Yildiz M, Isik E, Abali ZY, Keskin M, Ozbek MN, Bas F, Ucakturk SA, Buyukinan M, Onal H, Kara C, Storbeck KH, Darendeliler F, Cayir A, Unal E, Anik A, Demirbilek H, Cetin T, Dursun F, Catli G, Turan S, Falhammar H, Baris T, Yaman A, Haklar G, Bereket A, Guran T (2021) Clinical and hormonal profiles correlate with molecular characteristics in patients with 11\u03b2-hydroxylase deficiency. J Clin Endocrinol Metab 106:e3714\u2013e3724. https:\/\/doi.org\/10.1210\/clinem\/dgab225","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s12020-024-03746-y","volume":"84","author":"S Tang","year":"2024","unstructured":"Tang S, Xu W, Xuan M, Liu Q, Li Y, Kong D, Yang H, Liu Y, Xue Y (2024) Non-classical 11\u03b2-hydroxylase deficiency caused by a novel heterozygous mutation: a case report and review of the literature. Endocrine 84:1193\u20131205. https:\/\/doi.org\/10.1007\/s12020-024-03746-y","journal-title":"Endocrine"},{"key":"2750_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.steroids.2015.04.003","volume":"100","author":"X Wang","year":"2015","unstructured":"Wang X, Nie M, Lu L, Tong A, Chen S, Lu Z (2015) Identification of seven novel CYP11B1 gene mutations in Chinese patients with 11\u03b2-hydroxylase deficiency. Steroids 100:11\u201316. https:\/\/doi.org\/10.1016\/j.steroids.2015.04.003","journal-title":"Steroids"},{"key":"2750_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s12519-023-00739-1","volume":"20","author":"WL Lu","year":"2023","unstructured":"Lu WL, Ma XY, Zhang J, Wang JQ, Zhang TT, Ye L, Xiao Y, Dong ZY, Wang W, Sun SY, Li CY, Hu RG, Ning G, Zhang LD (2023) Clinical and molecular characterization of 10 Chinese children with congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. World J Pediatr 20:422\u2013433. https:\/\/doi.org\/10.1007\/s12519-023-00739-1","journal-title":"World J Pediatr"},{"key":"2750_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jsbmb.2012.08.011","volume":"133","author":"M Zhang","year":"2013","unstructured":"Zhang M, Liu Y, Sun S, Zhang H, Wang W, Ning G, Li X (2013) A prevalent and three novel mutations in CYP11B1 gene identified in Chinese patients with 11-beta hydroxylase deficiency. J Steroid Biochem Mol Biol 133:25\u201329. https:\/\/doi.org\/10.1016\/j.jsbmb.2012.08.011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jsbmb.2017.09.018","volume":"174","author":"AS Alzahrani","year":"2017","unstructured":"Alzahrani AS, Alswailem MM, Murugan AK, Alhomaidah DS, Capper CP, Auchus RJ, Qasem E, Alzahrani OS, Al-Sagheir A, Bin-Abbas B (2017) A high rate of novel CYP11B1 mutations in Saudi Arabia. J Steroid Biochem Mol Biol 174:217\u2013224. https:\/\/doi.org\/10.1016\/j.jsbmb.2017.09.018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR22","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1210\/jc.2005-0089","volume":"90","author":"N Krone","year":"2005","unstructured":"Krone N, Riepe FG, G\u00f6tze D, Korsch E, Rister M, Commentz J, Partsch CJ, Gr\u00f6tzinger J, Peter M, Sippell WG (2005) Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene. J Clin Endocrinol Metab 90:3724\u20133730. https:\/\/doi.org\/10.1210\/jc.2005-0089","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105899","volume":"211","author":"W Wang","year":"2021","unstructured":"Wang W, Han R, Yang Z, Zheng S, Li H, Wan Z, Qi Y, Sun S, Ye L, Ning G (2021) Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol 211:105899. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105899","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jsbmb.2018.04.001","volume":"181","author":"F Ba\u015f","year":"2018","unstructured":"Ba\u015f F, Toksoy G, Ergun-Longmire B, Uyguner ZO, Abal\u0131 ZY, Poyrazo\u011flu \u015e, Karaman V, Avc\u0131 \u015e, Altuno\u011flu U, Bundak R, Karaman B, Ba\u015faran S, Darendeliler F (2018) Prevalence, clinical characteristics and long-term outcomes of classical 11 \u03b2-hydroxylase deficiency (11BOHD) in Turkish population and novel mutations in CYP11B1 gene. J Steroid Biochem Mol Biol 181:88\u201397. https:\/\/doi.org\/10.1016\/j.jsbmb.2018.04.001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000281417","volume":"74","author":"L Chabraoui","year":"2010","unstructured":"Chabraoui L, Abid F, Menassa R, Gaouzi A, El Hessni A, Morel Y (2010) Three novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11Beta-hydroxylase deficiency in a Moroccan population. Horm Res Paediatr 74:182\u2013189. https:\/\/doi.org\/10.1159\/000281417","journal-title":"Horm Res Paediatr"},{"key":"2750_CR26","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1210\/jc.2008-2521","volume":"94","author":"FC Soardi","year":"2009","unstructured":"Soardi FC, Penachioni JY, Justo GZ, Bachega TA, In\u00e1cio M, Mendon\u00e7a BB, de Castro M, de Mello MP (2009) Novel mutations in CYP11B1 gene leading to 11 beta-hydroxylase deficiency in Brazilian patients. J Clin Endocrinol Metab 94:3481\u20133485. https:\/\/doi.org\/10.1210\/jc.2008-2521","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2009-0651","volume":"95","author":"S Parajes","year":"2010","unstructured":"Parajes S, Loidi L, Reisch N, Dhir V, Rose IT, Hampel R, Quinkler M, Conway GS, Castro-Feij\u00f3o L, Araujo-Vilar D, Pombo M, Dominguez F, Williams EL, Cole TR, Kirk JM, Kaminsky E, Rumsby G, Arlt W, Krone N (2010) Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with non-classic and three mutations causing classic 11{beta}-hydroxylase deficiency. J Clin Endocrinol Metab 95:779\u2013788. https:\/\/doi.org\/10.1210\/jc.2009-0651","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1530\/EJE-13-0737","volume":"170","author":"S Polat","year":"2014","unstructured":"Polat S, Kulle A, Karaca Z, Akkurt I, Kurtoglu S, Kelestimur F, Gr\u00f6tzinger J, Holterhus PM, Riepe FG (2014) Characterisation of three novel CYP11B1 mutations in classic and non-classic 11\u03b2-hydroxylase deficiency. Eur J Endocrinol 170:697\u2013706. https:\/\/doi.org\/10.1530\/EJE-13-0737","journal-title":"Eur J Endocrinol"},{"key":"2750_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12020-018-1691-4","volume":"62","author":"LP Valadares","year":"2018","unstructured":"Valadares LP, Pfeilsticker ACV, de Brito Sousa SM, Cardoso SC, de Moraes OL, Gon\u00e7alves de Castro LC, de Oliveira RS, Lofrano-Porto A (2018) Insights on the phenotypic heterogenity of 11\u03b2-hydroxylase deficiency: clinical and genetic studies in two novel families. Endocrine 62:326\u2013332. https:\/\/doi.org\/10.1007\/s12020-018-1691-4","journal-title":"Endocrine"},{"key":"2750_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","volume":"55","author":"K Bulsari","year":"2017","unstructured":"Bulsari K, Falhammar H (2017) Clinical perspectives in congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency. Endocrine 55:19\u201336. https:\/\/doi.org\/10.1007\/s12020-016-1189-x","journal-title":"Endocrine"},{"key":"2750_CR31","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.4158\/EP14179.CR","volume":"20","author":"B Bin-Abbas","year":"2014","unstructured":"Bin-Abbas B, Al-Humaida D, Al-Sagheir A, Qasem E, Almohanna M, Alzahrani AS (2014) Divergent gender identity in three siblings with 46XX karyotype and severely virilizing congenital adrenal hyperplasia caused by a novel CYP11B1 mutation. Endocr Pract 20:e191\u2013e197. https:\/\/doi.org\/10.4158\/EP14179.CR","journal-title":"Endocr Pract"},{"key":"2750_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1515\/JPEM.2005.18.2.133","volume":"18","author":"R Motaghedi","year":"2005","unstructured":"Motaghedi R, Betensky BP, Slowinska B, Cerame B, Cabrer M, New MI, Wilson RC (2005) Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J Pediatr Endocrinol Metab 18:133\u2013142. https:\/\/doi.org\/10.1515\/JPEM.2005.18.2.133","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2750_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1515\/jpem-2018-0298","volume":"32","author":"T Breil","year":"2019","unstructured":"Breil T, Yakovenko V, Inta I, Choukair D, Klose D, Mittnacht J, Schulze E, Alrajab A, Grulich-Henn J, Bettendorf M (2019) Typical characteristics of children with congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency: a single-centre experience and review of the literature. J Pediatr Endocrinol Metab 32:259\u2013267. https:\/\/doi.org\/10.1515\/jpem-2018-0298","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2750_CR34","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1210\/jc.2005-0379","volume":"90","author":"A Grigorescu Sido","year":"2005","unstructured":"Grigorescu Sido A, Weber MM, Grigorescu Sido P, Clausmeyer S, Heinrich U, Schulze E (2005) 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 90:5769\u20135773. https:\/\/doi.org\/10.1210\/jc.2005-0379","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.14310\/horm.2002.1651","volume":"15","author":"C Shammas","year":"2016","unstructured":"Shammas C, Byrou S, Phelan MM, Toumba M, Stylianou C, Skordis N, Neocleous V, Phylactou LA (2016) Genetic screening of non-classic CAH females with hyperandrogenemia identifies a novel CYP11B1 gene mutation. Hormones (Athens) 15:235\u2013242. https:\/\/doi.org\/10.14310\/horm.2002.1651","journal-title":"Hormones (Athens)"},{"key":"2750_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/jcrpe.3378","volume":"9","author":"S Kurto\u011flu","year":"2017","unstructured":"Kurto\u011flu S, Hatipo\u011flu N (2017) Non-classical congenital adrenal hyperplasia in childhood. J Clin Res Pediatr Endocrinol 9:1\u20137. https:\/\/doi.org\/10.4274\/jcrpe.3378","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2750_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000337974","volume":"77","author":"N Janzen","year":"2012","unstructured":"Janzen N, Riepe FG, Peter M, Sander S, Steuerwald U, Korsch E, Krull F, M\u00fcller HL, Heger S, Brack C, Sander J (2012) Neonatal screening: identification of children with 11\u03b2-hydroxylase deficiency by second-tier testing. Horm Res Paediatr 77:195\u2013199. https:\/\/doi.org\/10.1159\/000337974","journal-title":"Horm Res Paediatr"},{"key":"2750_CR38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/cen.14597","volume":"96","author":"G Barash","year":"2022","unstructured":"Barash G, Drach L, Naugolni L, Yacoel T, Bistritzer T, Rachmiel M (2022) Are current cut-off values of 11-DOC in children useful for assessing suspected non-classical congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency? Clin Endocrinol (Oxf) 96:302\u2013310. https:\/\/doi.org\/10.1111\/cen.14597","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2750_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0929-6646(09)60342-9","volume":"105","author":"SL Wong","year":"2006","unstructured":"Wong SL, Shu SG, Tsai CR (2006) Seventeen alpha-hydroxylase deficiency. J Formos Med Assoc 105:177\u2013181. https:\/\/doi.org\/10.1016\/S0929-6646(09)60342-9","journal-title":"J Formos Med Assoc"},{"key":"2750_CR40","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1210\/jc.2005-2283","volume":"91","author":"J Yang","year":"2006","unstructured":"Yang J, Cui B, Sun S, Shi T, Zheng S, Bi Y, Liu J, Zhao Y, Chen J, Ning G, Li X (2006) Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase\/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene. J Clin Endocrinol Metab 91:3619\u20133625. https:\/\/doi.org\/10.1210\/jc.2005-2283","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsbmb.2016.02.002","volume":"165","author":"RJ Auchus","year":"2017","unstructured":"Auchus RJ (2017) Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol 165:71\u201378. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.02.002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1210\/jc.2003-031021","volume":"89","author":"M Costa-Santos","year":"2004","unstructured":"Costa-Santos M, Kater CE, Auchus RJ, Group (2004) Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency. J Clin Endocrinol Metab 89:49\u201360. https:\/\/doi.org\/10.1210\/jc.2003-031021","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.gene.2012.12.010","volume":"516","author":"B Han","year":"2013","unstructured":"Han B, Liu W, Zuo CL, Zhu H, Li L, Xu C, Wang XJ, Liu BL, Pan CM, Lu YL, Wu WL, Chen MD, Song HD, Cheng KX, Qiao J (2013) Identifying a novel mutation of CYP17A1 gene from five Chinese 17\u03b1-hydroxylase\/17, 20-lyase deficiency patients. Gene 516:345\u2013350. https:\/\/doi.org\/10.1016\/j.gene.2012.12.010","journal-title":"Gene"},{"key":"2750_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/a-1100-7066","volume":"52","author":"FB Coeli-Lacchini","year":"2020","unstructured":"Coeli-Lacchini FB, Mermejo LM, Bodoni AF, Elias LLK, Silva WA Jr, Antonini SR, Moreira AC, de Castro M (2020) Clinical, Molecular, Functional, and structural characterization of CYP17A1 mutations in Brazilian patients with 17-Hydroxylase deficiency. Horm Metab Res 52:186\u2013193. https:\/\/doi.org\/10.1055\/a-1100-7066","journal-title":"Horm Metab Res"},{"key":"2750_CR45","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1515\/jpem-2017-0521","volume":"31","author":"ISS Breder","year":"2018","unstructured":"Breder ISS, Garmes HM, Mazzola TN, Maciel-Guerra AT, de Mello MP, Guerra-J\u00fanior G (2018) Three new Brazilian cases of 17\u03b1-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features. J Pediatr Endocrinol Metab 31:937\u2013942. https:\/\/doi.org\/10.1515\/jpem-2017-0521","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2750_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsbmb.2015.02.007","volume":"150","author":"M Zhang","year":"2015","unstructured":"Zhang M, Sun S, Liu Y, Zhang H, Jiao Y, Wang W, Li X (2015) New, recurrent, and prevalent mutations: clinical and molecular characterization of 26 Chinese patients with 17alpha-hydroxylase\/17,20-lyase deficiency. J Steroid Biochem Mol Biol 150:11\u201316. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.02.007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR47","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2265.2009.03607.x","volume":"72","author":"J Qiao","year":"2010","unstructured":"Qiao J, Chen X, Zuo CL, Gu YY, Liu BL, Liang J, Lu YL, Tang JF, Wu YX, Chen MD, Chen JL, Wu WL, Song HD (2010) Identification of steroid biosynthetic defects in genotype-proven heterozygous individuals for 17alpha-hydroxylase\/17,20-lyase deficiency. Clin Endocrinol (Oxf) 72:312\u2013319. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03607.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2750_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000529158","volume":"17","author":"I Dundar","year":"2023","unstructured":"Dundar I, Akinci A, Camtosun E, Ciftci N, Kayas L (2023) Presentation, diagnosis, and follow-up characteristics of 17\u03b1-hydroxylase deficiency cases with exon 1\u20136 deletion (founder mutation) in the CYP17A1 gene: 20-year single-center experience. Sex Dev 17:43\u201350. https:\/\/doi.org\/10.1159\/000529158","journal-title":"Sex Dev"},{"key":"2750_CR49","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/09513590.2014.895980","volume":"30","author":"YP Wang","year":"2014","unstructured":"Wang YP, Zhao YJ, Zhou GY, He B (2014) CYP17A1 gene mutations and hypertension variations found in 46, XY females with combined 17\u03b1-hydroxylase\/17, 20-lyase deficiency. Gynecol Endocrinol 30:456\u2013460. https:\/\/doi.org\/10.3109\/09513590.2014.895980","journal-title":"Gynecol Endocrinol"},{"key":"2750_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mce.2017.08.022","volume":"461","author":"MM Alswailem","year":"2018","unstructured":"Alswailem MM, Alzahrani OS, Alhomaidah DS, Alasmari R, Qasem E, Murugan AK, Alsagheir A, Brema I, Abbas BB, Almehthel M, Almeqbali A, Alzahrani AS (2018) Mutational analysis of rare subtypes of congenital adrenal hyperplasia in a highly inbred population. Mol Cell Endocrinol 461:105\u2013111. https:\/\/doi.org\/10.1016\/j.mce.2017.08.022","journal-title":"Mol Cell Endocrinol"},{"key":"2750_CR51","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1159\/000515079","volume":"93","author":"E Kurnaz","year":"2020","unstructured":"Kurnaz E, Kartal Baykan E, T\u00fcrky\u0131lmaz A, Yaral\u0131 O, Yava\u015f Abal\u0131 Z, Turan S, Bereket A, \u00c7ay\u0131r A, Guran T (2020) Genotypic sex and severity of the disease determine the time of clinical presentation in steroid 17\u03b1-hydroxylase\/17,20-lyase deficiency. Horm Res Paediatr 93:558\u2013566. https:\/\/doi.org\/10.1159\/000515079","journal-title":"Horm Res Paediatr"},{"key":"2750_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4274\/jcrpe.0032","volume":"10","author":"AD Kardelen","year":"2018","unstructured":"Kardelen AD, Toksoy G, Ba\u015f F, Yava\u015f Abal\u0131 Z, Gen\u00e7ay G, Poyrazo\u011flu \u015e, Bundak R, Altuno\u011flu U, Avc\u0131 \u015e, Najafl\u0131 A, Uyguner O, Karaman B, Ba\u015faran S, Darendeliler F (2018) A rare cause of congenital adrenal hyperplasia: clinical and genetic findings and follow-up characteristics of six patients with 17-hydroxylase deficiency including two novel mutations. J Clin Res Pediatr Endocrinol 10:206\u2013215. https:\/\/doi.org\/10.4274\/jcrpe.0032","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2750_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1530\/EJE-21-0152","volume":"185","author":"M Sun","year":"2021","unstructured":"Sun M, Mueller JW, Gilligan LC, Taylor AE, Shaheen F, Noczy\u0144ska A, T\u2019Sjoen G, Denvir L, Shenoy S, Fulton P, Cheetham TD, Gleeson H, Rahman M, Krone NP, Taylor NF, Shackleton CHL, Arlt W, Idkowiak J (2021) The broad phenotypic spectrum of 17\u03b1-hydroxylase\/17,20-lyase (CYP17A1) deficiency: a case series. Eur J Endocrinol 185:729\u2013741. https:\/\/doi.org\/10.1530\/EJE-21-0152","journal-title":"Eur J Endocrinol"},{"key":"2750_CR54","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa022","volume":"105","author":"T Guran","year":"2020","unstructured":"Guran T, Kara C, Yildiz M, Bitkin EC, Haklar G, Lin JC, Keskin M, Barnard L, Anik A, Catli G, Guven A, Kirel B, Tutunculer F, Onal H, Turan S, Akcay T, Atay Z, Yilmaz GC, Mamadova J, Akbarzade A, Sirikci O, Storbeck KH, Baris T, Chung BC, Bereket A (2020) Revisiting classical 3\u03b2-hydroxysteroid dehydrogenase 2 deficiency: lessons from 31 pediatric cases. J Clin Endocrinol Metab 105:e1718\u2013e1728. https:\/\/doi.org\/10.1210\/clinem\/dgaa022","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.867073","volume":"13","author":"A Ladjouze","year":"2022","unstructured":"Ladjouze A, Donaldson M, Plotton I, Djenane N, Mohammedi K, Tardy-Guidollet V, Mallet D, Boulesnane K, Bouzerar Z, Morel Y, Roucher-Boulez F (2022) Genotype, mortality, morbidity, and outcomes of 3\u03b2-hydroxysteroid dehydrogenase deficiency in Algeria. Front Endocrinol (Lausanne) 13:867073. https:\/\/doi.org\/10.3389\/fendo.2022.867073","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2750_CR56","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1210\/jc.2004-1552","volume":"90","author":"LM Mermejo","year":"2005","unstructured":"Mermejo LM, Elias LL, Marui S, Moreira AC, Mendonca BB, de Castro M (2005) Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping. J Clin Endocrinol Metab 90:1287\u20131293. https:\/\/doi.org\/10.1210\/jc.2004-1552","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR57","doi-asserted-by":"publisher","first-page":"E1105","DOI":"10.1210\/jc.2015-2098","volume":"100","author":"AR Benkert","year":"2015","unstructured":"Benkert AR, Young M, Robinson D, Hendrickson C, Lee PA, Strauss KA (2015) Severe Salt-Losing 3\u03b2-Hydroxysteroid dehydrogenase deficiency: treatment and outcomes of HSD3B2 c.35G\u2009>\u2009A homozygotes. J Clin Endocrinol Metab 100:E1105\u2013E1115. https:\/\/doi.org\/10.1210\/jc.2015-2098","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.17219\/acem\/131220","volume":"30","author":"L Chen","year":"2021","unstructured":"Chen L, Huang H, Zhang H, Zhu G, Zhu M (2021) Three cases of 3\u03b2-hydroxysteroid dehydrogenase deficiency: clinical analysis. Adv Clin Exp Med 30:289\u2013299. https:\/\/doi.org\/10.17219\/acem\/131220","journal-title":"Adv Clin Exp Med"},{"key":"2750_CR59","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1210\/jc.2009-1460","volume":"94","author":"T Sahakitrungruang","year":"2009","unstructured":"Sahakitrungruang T, Huang N, Tee MK, Agrawal V, Russell WE, Crock P, Murphy N, Migeon CJ, Miller WL (2009) Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. J Clin Endocrinol Metab 94:4992\u20135000. https:\/\/doi.org\/10.1210\/jc.2009-1460","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR60","doi-asserted-by":"publisher","first-page":"E257","DOI":"10.1210\/jc.2011-0640","volume":"97","author":"N Krone","year":"2012","unstructured":"Krone N, Reisch N, Idkowiak J, Dhir V, Ivison HE, Hughes BA, Rose IT, O\u2019Neil DM, Vijzelaar R, Smith MJ, MacDonald F, Cole TR, Adolphs N, Barton JS, Blair EM, Braddock SR, Collins F, Cragun DL, Dattani MT, Day R, Dougan S, Feist M, Gottschalk ME, Gregory JW, Haim M, Harrison R, Olney AH, Hauffa BP, Hindmarsh PC, Hopkin RJ, Jira PE, Kempers M, Kerstens MN, Khalifa MM, K\u00f6hler B, Maiter D, Nielsen S, O\u2019Riordan SM, Roth CL, Shane KP, Silink M, Stikkelbroeck NM, Sweeney E, Szarras-Czapnik M, Waterson JR, Williamson L, Hartmann MF, Taylor NF, Wudy SA, Malunowicz EM, Shackleton CH, Arlt W (2012) Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab 97:E257\u2013E267. https:\/\/doi.org\/10.1210\/jc.2011-0640","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1283-2","volume":"14","author":"L Fan","year":"2019","unstructured":"Fan L, Ren X, Song Y, Su C, Fu J, Gong C (2019) Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children. Orphanet J Rare Dis 14:299. https:\/\/doi.org\/10.1186\/s13023-019-1283-2","journal-title":"Orphanet J Rare Dis"},{"key":"2750_CR62","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1507\/endocrj.EJ20-0011","volume":"67","author":"S Yatsuga","year":"2020","unstructured":"Yatsuga S, Amano N, Nakamura-Utsunomiya A, Kobayashi H, Takasawa K, Nagasaki K, Nakamura A, Nishigaki S, Numakura C, Fujiwara I, Minamitani K, Hasegawa T, Tajima T (2020) Clinical characteristics of cytochrome P450 oxidoreductase deficiency: a nationwide survey in Japan. Endocr J 67:853\u2013857. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0011","journal-title":"Endocr J"},{"key":"2750_CR63","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1210\/jc.2010-1607","volume":"96","author":"J Idkowiak","year":"2011","unstructured":"Idkowiak J, O\u2019Riordan S, Reisch N, Malunowicz EM, Collins F, Kerstens MN, K\u00f6hler B, Graul-Neumann LM, Szarras-Czapnik M, Dattani M, Silink M, Shackleton CH, Maiter D, Krone N, Arlt W (2011) Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab 96:E453\u2013E462. https:\/\/doi.org\/10.1210\/jc.2010-1607","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR64","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(04)16503-3","volume":"363","author":"W Arlt","year":"2004","unstructured":"Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH (2004) Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363:2128\u20132135. https:\/\/doi.org\/10.1016\/S0140-6736(04)16503-3","journal-title":"Lancet"},{"key":"2750_CR65","doi-asserted-by":"publisher","first-page":"e3929","DOI":"10.1210\/clinem\/dgaa557","volume":"105","author":"T Ishii","year":"2020","unstructured":"Ishii T, Tajima T, Kashimada K, Mukai T, Tanahashi Y, Katsumata N, Kanno J, Hamajima T, Miyako K, Ida S, Hasegawa T (2020) Clinical features of 57 patients with lipoid congenital adrenal hyperplasia: criteria for Non-classic form revisited. J Clin Endocrinol Metab 105:e3929\u20133937. https:\/\/doi.org\/10.1210\/clinem\/dgaa557","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR66","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1530\/EJE-11-0597","volume":"165","author":"JM Kim","year":"2011","unstructured":"Kim JM, Choi JH, Lee JH, Kim GH, Lee BH, Kim HS, Shin JH, Shin CH, Kim CJ, Yu J, Lee DY, Cho WK, Suh BK, Lee JE, Chung HR, Yoo HW (2011) High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia. Eur J Endocrinol 165:771\u2013778. https:\/\/doi.org\/10.1530\/EJE-11-0597","journal-title":"Eur J Endocrinol"},{"key":"2750_CR67","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1210\/jc.2005-0434","volume":"90","author":"A Bhangoo","year":"2005","unstructured":"Bhangoo A, Gu WX, Pavlakis S, Anhalt H, Heier L, Ten S, Jameson JL (2005) Phenotypic features associated with mutations in steroidogenic acute regulatory protein. J Clin Endocrinol Metab 90:6303\u20136309. https:\/\/doi.org\/10.1210\/jc.2005-0434","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR68","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.steroids.2016.01.016","volume":"108","author":"Z Huang","year":"2016","unstructured":"Huang Z, Ye J, Han L, Qiu W, Zhang H, Yu Y, Liang L, Gong Z, Gu X (2016) Identification of five novel STAR variants in ten Chinese patients with congenital lipoid adrenal hyperplasia. Steroids 108:85\u201391. https:\/\/doi.org\/10.1016\/j.steroids.2016.01.016","journal-title":"Steroids"},{"key":"2750_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105788","volume":"206","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma X, Wang J, Jia C, Wang W, Dong Z, Ye L, Sun S, Hu R, Ning G, Li C, Lu W (2021) Clinical and molecular characterization of thirty Chinese patients with congenital lipoid adrenal hyperplasia. J Steroid Biochem Mol Biol 206:105788. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105788","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR70","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1210\/jc.2007-1306","volume":"92","author":"M Abdulhadi-Atwan","year":"2007","unstructured":"Abdulhadi-Atwan M, Jean A, Chung WK, Meir K, Ben Neriah Z, Stratigopoulos G, Oberfield SE, Fennoy I, Hirsch HJ, Bhangoo A, Ten S, Lerer I, Zangen DH (2007) Role of a founder c.201_202delCT mutation and new phenotypic features of congenital lipoid adrenal hyperplasia in Palestinians. J Clin Endocrinol Metab 92:4000\u20134008. https:\/\/doi.org\/10.1210\/jc.2007-1306","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR71","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/cen.15032","volume":"100","author":"A Phadte","year":"2024","unstructured":"Phadte A, Dhole C, Hegishte S, Sarathi V, Lila A, Gada JV, Memon SS, Arya S, Karlekar M, Patil V, Varthakavi PK, Shah N, Bhagwat NM, Bandgar T (2024) Steroidogenic acute regulatory protein (STAR) deficiency: our experience and systematic review for phenotype-genotype correlation. Clin Endocrinol (Oxf) 100:431\u2013440. https:\/\/doi.org\/10.1111\/cen.15032","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2750_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105635","volume":"200","author":"H Chen","year":"2020","unstructured":"Chen H, Zhang Q, Chen R, Yuan X, Lin X, Yang X, Zhang Y (2020) Lipoid congenital adrenal hyperplasia due to steroid acute regulatory protein (STAR) variants in three Chinese patients. J Steroid Biochem Mol Biol 200:105635. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105635","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2750_CR73","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1210\/jc.2010-0437","volume":"95","author":"T Sahakitrungruang","year":"2010","unstructured":"Sahakitrungruang T, Soccio RE, Lang-Muritano M, Walker JM, Achermann JC, Miller WL (2010) Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab 95:3352\u20133359. https:\/\/doi.org\/10.1210\/jc.2010-0437","journal-title":"J Clin Endocrinol Metab"},{"key":"2750_CR74","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1210\/jc.2012-2828","volume":"98","author":"MK Tee","year":"2013","unstructured":"Tee MK, Abramsohn M, Loewenthal N, Harris M, Siwach S, Kaplinsky A, Markus B, Birk O, Sheffield VC, Parvari R, Hershkovitz E, Miller WL (2013) Varied clinical presentations of seven patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc. J Clin Endocrinol Metab 98:713\u2013720. https:\/\/doi.org\/10.1210\/jc.2012-2828","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02750-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:17:42Z","timestamp":1774415862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02750-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":74,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["2750"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02750-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no conflict of interest that could compromise the impartiality of the research reported and that no financial support was requested for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}}]}}